Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» chimeric antigen receptor T-cell immunotherapies
chimeric antigen receptor T-cell immunotherapies
Bluebird Bio and Five Prime Therapeutics Enter into License Agreement for Novel Antibodies to Develop Chimeric Antigen Receptor T Cell Therapy
Yahoo
Tue, 05/26/15 - 04:23 pm
Bluebird Bio
Five Prime
R&D
chimeric antigen receptor T-cell immunotherapies
Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy
Yahoo
Mon, 03/30/15 - 11:11 am
Intrexon
Merck Serono
CAR-T
chimeric antigen receptor T-cell immunotherapies
Cellectis Sees Independent Future After Pfizer Deal
TheStreet.com
Mon, 06/23/14 - 06:21 pm
Cellectis
Pfizer
chimeric antigen receptor T-cell immunotherapies